InvestSMART

Zelira Therapeutics Limited (ASX: ZLD) - Announcements

- Current share price for ZLD : $0.500

ASX company news and announcements for Zelira Therapeutics Limited (ZLD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Zelira Therapeutics Limited (ZLD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Zelira Therapeutics Limited (ZLD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Zelira Therapeutics Limited (ZLD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$7 Appendix 4G 30 Aug 2019 6:02PM $0.067 $0.500 risen by 646.27%
$7 Appendix 4E & Financial Statements 30 Aug 2019 5:56PM $0.067 $0.500 risen by 646.27%
$7 Zeldas Autism Observational Study Recruits 100th Participant 22 Aug 2019 8:42AM $0.069 $0.500 risen by 624.64%
$7 June 2019 Quarterly Report 31 Jul 2019 10:59AM $0.082 $0.500 risen by 509.76%
$7 Appendix 4C - quarterly 31 Jul 2019 10:59AM $0.082 $0.500 risen by 509.76%
$7 US Non-deal Roadshow - Investor Presentation 22 Jul 2019 9:55AM $0.072 $0.500 risen by 594.44%
$7 Appendix 3B and Cleansing Notice - Exercise of Options 19 Jul 2019 5:27PM $0.072 $0.500 risen by 594.44%
$7 Zelda Collaborates with Emerald Clinics 18 Jul 2019 4:24PM $0.067 $0.500 risen by 646.27%
$7 Response to ASX Price and Volume Query 11 Jul 2019 9:46AM $0.066 $0.500 risen by 657.58%
$7 Investor Presentation - Non-deal Roadshow 10 Jul 2019 11:15AM $0.061 $0.500 risen by 719.67%
$7 Zelda Granted Approval for Opioid Reduction Trial 2 Jul 2019 8:23AM $0.042 $0.500 risen by 1,090.48%
$7 Change in substantial holding 11 Jun 2019 6:00PM $0.042 $0.500 risen by 1,090.48%
$7 Change of Director's Interest Notice x 3 11 Jun 2019 4:13PM $0.042 $0.500 risen by 1,090.48%
$7 Director Shareholding Changes and Strategic Investment 11 Jun 2019 8:39AM $0.041 $0.500 risen by 1,119.51%
$7 Investor Presentation - Non-deal Roadshow 13 May 2019 10:29AM $0.046 $0.500 risen by 986.96%
$7 R&D Tax Incentive Refund 9 May 2019 8:22AM $0.044 $0.500 risen by 1,036.36%
$7 Appendix 4C - quarterly 30 Apr 2019 9:00AM $0.043 $0.500 risen by 1,062.79%
$7 March 2019 Quarterly Report 30 Apr 2019 8:59AM $0.043 $0.500 risen by 1,062.79%
$7 Zelda Partners with Ilera HealthCare 12 Mar 2019 8:23AM $0.057 $0.500 risen by 777.19%
$7 Aus Patent For Novel Prognostic Marker for Breast Cancer 6 Mar 2019 9:25AM $0.056 $0.500 risen by 792.86%
$7 Novel Cannabis Pathway for Treatment of Breast Cancer 28 Feb 2019 8:32AM $0.053 $0.500 risen by 843.40%
$7 Appendix 4D & FY19 Interim Financial Report 22 Feb 2019 7:36PM $0.054 $0.500 risen by 825.93%
$7 Appendix 3B 19 Feb 2019 4:06PM $0.055 $0.500 risen by 809.09%
$7 Results of Meeting 18 Feb 2019 12:32PM $0.060 $0.500 risen by 733.33%
$7 ZLD Engages ICCI for Clinical Trial and Regulatory Expertise 12 Feb 2019 8:25AM $0.058 $0.500 risen by 762.07%

376 - 400 of 545 results

Page 16 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.